{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T20:32:19Z","timestamp":1777494739020,"version":"3.51.4"},"reference-count":48,"publisher":"University of Toronto Press Inc. (UTPress)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the Association of Medical Microbiology and Infectious Disease Canada"],"published-print":{"date-parts":[[2021,5,3]]},"abstract":"<jats:p> Background: A revised consensus guideline on therapeutic drug monitoring (TDM) of vancomycin for serious methicillin-resistant Staphylococcus aureus (MRSA) infections was recently published with endorsement of numerous American pharmacy and medical societies. Changing practice from trough TDM to area-under-the-curve-(AUC)-guided dosing was suggested. Methods: Recent literature was critically appraised to determine whether AUC TDM is appropriate for Canadian hospital practice. Results: Previous 2009 vancomycin consensus guidelines recommended trough levels of 15\u201320\u00a0mg\/L for serious MRSA infections, based on relatively poor evidence for efficacy or safety. In the past decade, aggressive trough targets have led to unnecessary toxicity. Adoption of a TDM strategy using an alternative parameter (AUC) has been suggested, although the evidence for any outcome benefits is low quality. In addition, implementation would require greater resources at health care institutions in the forms of more frequent serum levels or acquisition of costly Bayesian software programs. Most studies on this subject have been observational and retrospective; therefore, relationships between TDM parameters and outcomes have not been convincingly and consistently demonstrated to be causal in nature. Despite claims to the contrary, based on few in silico experiments, available clinical data suggest correlation of trough levels and AUC is high. TDM with lower target trough levels is a simpler solution to reduce risk of toxicity. Conclusions: There are serious concerns with adoption of AUC TDM of vancomycin into routine practice in Canada. Trough-based monitoring with modest reduction in target levels remains the most evidence-informed practice at this time. <\/jats:p>","DOI":"10.3138\/jammi-2020-0028","type":"journal-article","created":{"date-parts":[[2021,3,3]],"date-time":"2021-03-03T22:13:19Z","timestamp":1614809599000},"page":"3-9","source":"Crossref","is-referenced-by-count":7,"title":["A Canadian perspective on the revised 2020 ASHP\u2013IDSA\u2013PIDS\u2013SIDP guidelines for vancomycin AUC-based therapeutic drug monitoring for serious MRSA infections"],"prefix":"10.3138","volume":"6","author":[{"given":"Jackson J","family":"Stewart","sequence":"first","affiliation":[{"name":"Pharmacy Department, Alberta Health Services, Edmonton, Alberta, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah CJ","family":"Jorgensen","sequence":"additional","affiliation":[{"name":"Pharmacy Department, Mount Sinai Hospital, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Dresser","sequence":"additional","affiliation":[{"name":"Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada"},{"name":"Department of Pharmacy, Sinai Health System, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim TY","family":"Lau","sequence":"additional","affiliation":[{"name":"Pharmaceutical Sciences, Vancouver General Hospital, Vancouver, British Columbia, Canada"},{"name":"Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, British Columbia, Canada"},{"name":"Division of Infectious Diseases, Faculty of Medicine, The University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfred","family":"Gin","sequence":"additional","affiliation":[{"name":"Winnipeg Regional Health Authority Regional Pharmacy Program, Winnipeg, Manitoba, Canada"},{"name":"Department of Medical Microbiology and Infectious Diseases, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel JG","family":"Thirion","sequence":"additional","affiliation":[{"name":"Pharmacy Department, McGill University Health Centre, Montreal, Quebec, Canada"},{"name":"Faculty of Pharmacy, University of Montreal, Montreal, Quebec, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cesilia","family":"Nishi","sequence":"additional","affiliation":[{"name":"Pharmaceutical Sciences, Vancouver General Hospital, Vancouver, British Columbia, Canada"},{"name":"Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, British Columbia, Canada"},{"name":"Division of Infectious Diseases, Faculty of Medicine, The University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce","family":"Dalton","sequence":"additional","affiliation":[{"name":"Pharmacy Department, Alberta Health Services, Edmonton, Alberta, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1696","reference":[{"issue":"11","key":"r1","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/ajhp\/zxaa036","volume":"77","author":"Rybak MJ","year":"2020","journal-title":"Am JxHealth Syst Pharm"},{"issue":"1","key":"r2","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2146\/ajhp080434","volume":"66","author":"Rybak M","year":"2009","journal-title":"Am J Health Syst Pharm"},{"key":"r3","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1093\/ajhp\/57.suppl_2.S4","volume":"57","author":"Moise PA","year":"2000","journal-title":"Am J Health Syst Pharm"},{"issue":"19","key":"r4","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1001\/archinte.166.19.2138","volume":"166","author":"Hidayat LK","year":"2006","journal-title":"Arch Intern Med"},{"issue":"4","key":"r5","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1093\/jac\/dkm258","volume":"60","author":"Steinkraus G","year":"2007","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"r6","doi-asserted-by":"crossref","first-page":"P140","DOI":"10.1016\/j.jinf.2009.11.011","volume":"60","author":"Ho PL","year":"2010","journal-title":"J Infect"},{"issue":"2","key":"r7","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.cmi.2017.06.017","volume":"24","author":"Diaz R","year":"2018","journal-title":"Clin Microbiol Infect"},{"issue":"12","key":"r8","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1002\/phar.2191","volume":"38","author":"Turner RB","year":"2018","journal-title":"Pharmacotherapy"},{"issue":"10","key":"r9","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.cmi.2019.02.029","volume":"25","author":"Broeker A","year":"2019","journal-title":"Clin Microbiol Infect"},{"issue":"10","key":"r10","doi-asserted-by":"crossref","first-page":"4581","DOI":"10.1128\/AAC.00115-11","volume":"55","author":"Moore CL","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"r11","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.cmi.2019.10.029","volume":"26","author":"Dalton BR","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"r12","first-page":"377","volume-title":"Clinical pharmacokinetics","author":"Duby J","year":"2017"},{"issue":"2","key":"r13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.02042-17","volume":"62","author":"Neely MN","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"r14","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1128\/AAC.01568-12","volume":"57","author":"Van Hal SJ","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"r15","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1093\/jac\/dkaa184","volume":"75","author":"Bellos I","year":"2020","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"12","key":"r16","first-page":"e01293","volume":"61","author":"Finch NA","year":"2017","journal-title":"Antimicrobial Agents"},{"issue":"10","key":"r17","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/phar.1638","volume":"35","author":"Prybylski JP","year":"2015","journal-title":"Pharmacotherapy"},{"issue":"4","key":"r18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0214309","volume":"14","author":"Yahav D","year":"2019","journal-title":"PLoS One"},{"issue":"15","key":"r19","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1161\/CIR.0000000000000296","volume":"132","author":"Baddour LM","year":"2015","journal-title":"Circulation"},{"key":"r20","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.addr.2014.05.016","volume":"77","author":"Pai MP","year":"2014","journal-title":"Adv Drug Deliv Rev"},{"issue":"12","key":"r21","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1086\/518451","volume":"44","author":"Mohr JF","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"8","key":"r22","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1093\/cid\/cir078","volume":"52","author":"Patel N","year":"2011","journal-title":"Clin Infect Dis"},{"key":"r23","volume-title":"Applied statistics for the behavioral sciences","author":"Hinkle DE","year":"2003"},{"issue":"3","key":"r24","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3200\/JEXE.74.3.249-266","volume":"74","author":"Goodwin LD","year":"2006","journal-title":"J Exp Educ"},{"key":"r25","doi-asserted-by":"crossref","first-page":"P151","DOI":"10.1016\/j.ijid.2019.12.036","volume":"92","author":"Issaranggoon na Ayuthaya S","year":"2020","journal-title":"Int J\u00a0Infect Dis"},{"issue":"12","key":"r26","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1002\/jcph.1498","volume":"59","author":"Suchartlikitwong P","year":"2019","journal-title":"J Clin Pharmacol"},{"issue":"1","key":"r27","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3947\/ic.2014.46.1.21","volume":"46","author":"Jin SJ","year":"2014","journal-title":"Infect Chemother"},{"issue":"5","key":"r28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.02535-16","volume":"61","author":"Chavada R","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"r29","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jiac.2016.11.009","volume":"23","author":"Kato H","year":"2017","journal-title":"J Infect Chemother"},{"issue":"5","key":"r30","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s12098-019-03162-5","volume":"87","author":"Alsultan A","year":"2020","journal-title":"Indian J Pediatr"},{"issue":"4","key":"r31","doi-asserted-by":"crossref","first-page":"e109","DOI":"10.1093\/jpids\/piu110","volume":"4","author":"Le J","year":"2015","journal-title":"J Pediatric Infect Dis Soc"},{"issue":"3","key":"r32","first-page":"801","volume":"72","author":"De Cock PAJG","year":"2017","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"6","key":"r33","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s13318-019-00568-6","volume":"44","author":"Sridharan K","year":"2019","journal-title":"Eur J Drug Metab Pharmacokinet"},{"issue":"4","key":"r34","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.diagmicrobio.2018.06.022","volume":"92","author":"Turner RB","year":"2018","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"1","key":"r35","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/bcpt.13303","volume":"126","author":"Zhang T","year":"2020","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"9","key":"r36","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1002\/jcph.1254","volume":"58","author":"Abulfathi AA","year":"2018","journal-title":"J Clin Pharmacol"},{"issue":"1","key":"r37","first-page":"41","volume":"22","author":"Kishk OA","year":"2017","journal-title":"J Pediatr Pharmacol Ther"},{"issue":"2","key":"r38","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/MPH.0000000000000470","volume":"38","author":"Seixas GTF","year":"2016","journal-title":"J Pediatr Hematol Oncol"},{"issue":"1","key":"r39","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/FTD.0000000000000359","volume":"39","author":"Kamel AB","year":"2017","journal-title":"Ther Drug Monit"},{"issue":"4","key":"r40","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/FTD.0000000000000622","volume":"41","author":"Clark L","year":"2019","journal-title":"Ther Drug Monit"},{"issue":"5","key":"r41","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/FTD.0000000000000190","volume":"37","author":"Hahn A","year":"2015","journal-title":"Ther Drug Monit"},{"issue":"1","key":"r42","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/FTD.0000000000000250","volume":"38","author":"Haeseker M","year":"2016","journal-title":"Ther Drug Monit"},{"issue":"4","key":"r43","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.jmii.2015.08.027","volume":"50","author":"Hwang D","year":"2017","journal-title":"J\u00a0Microbiol Immunol Infect"},{"issue":"2","key":"r44","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/bcp.14144","volume":"86","author":"Smit C","year":"2020","journal-title":"Br J Clin Pharmacol"},{"issue":"13","key":"r45","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1200\/JCO.2007.13.3934","volume":"26","author":"Gamelin E","year":"2008","journal-title":"J Clin Oncol"},{"issue":"9","key":"r46","first-page":"2039","volume":"4","author":"Fety R","year":"1998","journal-title":"Clin Cancer Res"},{"issue":"4","key":"r47","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.clcc.2014.09.007","volume":"13","author":"Goldstein DA","year":"2014","journal-title":"Clin Colorectal Cancer"},{"issue":"3","key":"r48","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/cpt.1124","volume":"105","author":"Beumer JH","year":"2019","journal-title":"Clin Pharmacol Ther"}],"container-title":["Journal of the Association of Medical Microbiology and Infectious Disease Canada"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/utppublishing.com\/doi\/pdf\/10.3138\/jammi-2020-0028","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T15:32:52Z","timestamp":1741879972000},"score":1,"resource":{"primary":{"URL":"https:\/\/utppublishing.com\/doi\/10.3138\/jammi-2020-0028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,3]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,5,3]]}},"alternative-id":["10.3138\/jammi-2020-0028"],"URL":"https:\/\/doi.org\/10.3138\/jammi-2020-0028","relation":{},"ISSN":["2371-0888"],"issn-type":[{"value":"2371-0888","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,3]]}}}